Table 5 Effect of treatment with Cyclophosphamide or abnormal Savda Munziq traditional Uyghur Medicine in Mice Transplanted with S180 Tumour, on the percentage of CD 3 + , CD 4 + , CD 8 + and CD 4 /CD 8 ratio (m ± SD)
From: Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
Group | Dosage g/kg) | CD3 +T cell (%) | CD4 +T cell (%) | CD8 +T cell (%) | CD4/CD8ratio |
|---|---|---|---|---|---|
Control | 0 | 60.0 ± 9.6 | 43.4 ± 10.1 | 22.9 ± 2.9 | 1.88 ± 0.30 |
Model | 0 | 54.6 ± 9.0 | 37.7 ± 9.7 | 23.6 ± 5.8 | 1.62 ± 0.31 |
CY | 0.02 | 53.4 ± 9.1 | 39.6 ± 7.6 | 22.0 ± 3.4 | 1.80 ± 0.25 |
ASMq | 2 | 49.0 ± 10.9*# | 28.3 ± 8.7 | 19.2 ± 5.8 | 1.52 ± 0.37 |
ASMq | 4 | 58.2 ± 16.3 | 38.0 ± 9.0 | 21.1 ± 6.0 | 1.85 ± 0.38 |
ASMq | 8 | 45.1 ± 7.8*# | 28.6 ± 7.5 | 14.7 ± 3.0*# | 1.85 ± 0.49 |